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The prevalence of overweightness and obesity have increased in the United States (US) and most of the Westernized World over recent decades, reaching epidemic proportions. 1 It has been reported that one third of the adult population in North America is obese. 2 . More concerning, however, is that the prevalence of severe or Class III obesity *body mass index (BMI) ≥ 40 kg/m 2 ] has been increasing more so than obesity per se, now totaling over 3% of the US population. 1, 3 Certainly, obesity and severe obesity have placed a "heavy" toll on the cardiovascular (CV) system, markedly worsening many of the major CV risk factors, including increasing blood pressure (BP), glucose/metabolic syndrome (MetS)/diabetes mellitus (DM), lipids, and levels of inflammation, as well as having adverse effects on cardiac structure and function. The link between severity of obesity and cardiometabolic risk factors has recently been observed even at early stages in life 4 All together, the increase of obesity and severe obesity, as well as its related-disorders has led to an increase in the prevalence of hypertension (HTN), coronary heart disease (CHD), heart failure (HF), atrial fibrillation (AF), and other CV diseases (CVD). [1] [2] [3] [4] [5] [6] [7] Despite the adverse effects of obesity on the CV risk factors and the increased prevalence of various CVD, now many large studies and even meta-analyses have demonstrated a strong obesity paradox, where overweight and at least mildly obese patients with known CVD seem to have a better short-and, at least, moderate-term prognosis than do leaner patients with the same CVD, which has been termed "the Obesity Paradox." 3, [7] [8] [9] In this review, we are discussing briefly the adverse effects of obesity on CVD but mostly emphasize the studies regarding obesity and prognosis in patients with established CVD. In light of the obesity paradox, we also review data on the benefits and risks of weight loss for patients with CVD and the potential interaction of physical activity, cardiorespiratory fitness (CRF) and the obesity paradox.
cardiac work. These changes also lead to left ventricular (LV) dilatation and LV hypertrophy (LVH), both of the eccentric but also the concentric type, the latter particularly occurring when accompanied by HTN that is so prevalent in obesity. [5] [6] [7] 20 Additionally, obesity leads to enlargement of the left atrium (LA), from both increased blood volume and also diastolic ventricular dysfunction, which is common in obesity. 20, 21 Certainly, LA enlargement itself markedly worsens prognosis. 22, 23 For multiple mechanisms, obesity has adverse effects on both systolic, but, particularly, on LV diastolic dysfunction, as recently reviewed in relationship to HF.
3-5

Obesity and Impact on CVD and Prognosis-The Obesity Paradox
Due to the adverse effects that obesity has on CV risk factors and CV structure and function, not surprisingly, the prevalence of almost all CVD is increased in the setting of obesity, however, many studies have demonstrated surprisingly good prognosis among overweight and at least mildly obese patients with CVD, the so-called obesity paradox. 3, 7, 8 Hypertension. Overweight and obese patients have a considerably higher prevalence of HTN compared with lean subjects, [1] [2] [3] 5, 7 and obesity increases the CHD risk factors that accompany HTN and which should worsen prognosis, [3] [4] [5] [6] and markedly increases the prevalence of LV geometric abnormalities, including both concentric remodeling and eccentric and concentric LVH, all of which typically worsens prognosis. 5, 20 However, several studies have demonstrated that overweight and obese patients with HTN seem to have a better prognosis than do lean patients with HTN. 3, 24 Although the mechanisms for this is unclear, possibly lower levels of plasma renin activity in obesity could be involved. shows the best survival in the overweight group, and a trend for better survival in the Class I obese group, but higher mortality in those with more severe degrees of obesity.
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Recently, some studies have demonstrated an increased risk for CHD patients with "normal weight obesity" and "normal weight central obesity," in which % BF or WC, respectively, is high, although BMI may be in the normal range, 33-35 whereas we actually demonstrated an obesity paradox in Some studies have raised the possibility that the association with lower adiposity and worse clinical outcomes in CHD may represent a "lean paradox" even more so than an "obesity paradox."
26,39,40
Indeed, we have demonstrated this paradox with low BF and low BMI, 25-27 where low BF and low BMI are independent predictors of higher mortality. 26 However, in a study of 581 CHD patients, we demonstrate only those with both low BF and low BMI had a higher mortality (4 times higher) than did the other groups. 26 More recently, we demonstrated that both low BF and low lean mass (or non-fat mass) was associated with the worst survival, whereas those with the highest BF and the highest lean mass had the best survival (Figure 2) . 28 Other studies have suggested that there is more of an "overweight paradox," since the overweight group often seem to have the best prognosis.
Heart Failure. The impact of obesity to worsen LV structure and function and increase the prevalence of HF, 3, 5, 7, 9 yet be associated with a better survival in HF have recently been reviewed in detail, 3, 5, 7, 9 including in this Journal. 41, 42 In fact, a recent meta-analysis of 6 studies (n=22,807) has shown the highest risk of adverse events, including CV mortality, all-cause mortality, and re-hospitalizations
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during a mean 2.9 year follow-up, were in those with low BMI, whereas the lowest risk occurred in the overweight BMI. 43 Another recent study of 6,142 patients with acutely decompensated HF from 12
prospective studies from 4 continents also demonstrated a strong obesity paradox, although this report found that the paradox was largely confined to older HF patients and those with reduced LV function, recent-onset HF, and those with less metabolic illness. 44 Additionally, a recent report from the Cleveland Clinic found that although an obesity paradox was evident, this largely disappeared after adjustment for confounders, and then was largely confined to women in the overweight BMI range.
9,45
Atrial Fibrillation. AF is the most common arrhythmia worldwide and has significant impact on morbidity and mortality. [46] [47] [48] Moreover, incidence and prevalence of AF is expected to increase in the US and worldwide during the next few decades, due to both aging of the population but also due to the epidemics of obesity and MetS. 46 Multiple studies have shown an association between obesity and AF, which may be multifactorial, by increasing LA size and volume. 46 Additionally, obesity is an independent predictor of CVD and LV diastolic dysfunction, which both increase the risk of AF. 3, 7, 46 In fact, a meta-analysis of 16 studies evaluating nearly 125,000 individuals demonstrated that obese have nearly a 50% increased risk of developing AF compared with non-obese individuals. 49 Importantly, a large prospective communitybased observational cohort study demonstrated an approximately 4% increase in AF risk per 1-unit increase in BMI in men and women. 50 Additionally, evidence suggest that obesity may also be a risk factor for the progression of paroxysmal AF to persistent AF, which carries a higher morbidity and mortality.
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However, as in patients with HTN, CHD, and HF, overweight and obese patients with AF also demonstrate an obesity paradox, having a nearly 50% reduction in CV and all-cause mortality compared with AF patients with normal BMI.
3,52,53
Mechanisms of the Obesity Paradox
The mechanisms of this obesity paradox in various CVD are difficult to reconcile, although several potential mechanisms are listed in Table 2 . 3 Certainly, it has been argued that some of the obesity paradox may be due to the inaccuracies of BMI to assess true body fatness, 57 Finally, racial differences may also exist. The mortality risk in African-American Veterans with type 2 DM and BMI <25.0 kg/m 2 was substantially higher than the risk of their Caucasian counterparts. 58 .
Impact of Severity of Obesity
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The prevalence of Class III or "morbid" obesity (BMI ≥ 40 kg/m 2 ) has been dramatically increasing and is now present in over 3% of the US population. 1, 2 Although an obesity paradox exists, sometimes even in short-term follow-up even with extreme obesity, generally more severe obesity in long-term follow-up is associated with an ominous prognosis. 3, 8, 31, 59, 60 Therefore, the obesity paradox is probably more of an "overweight paradox" or at least more confined to those in the mildly obese groups. More severe obesity is a major risk factor for development and progression of CVD and is generally associated with a poor prognosis. Therefore, efforts to prevent and treat moderate and, especially, severe obesity are urgently needed.
Impact of Cardiorespiratory Fitness
Body fatness and CRF are strong predictors of CVD risk factors, as well as CV morbidity and mortality. 3, [61] [62] [63] [64] In most CVD, patients with high levels of CRF have lower mortality than do patients without this disorder but with low levels of CRF. 2 In a major meta-analysis of 33 studies of over 100,000 participants where CRF was assessed by treadmill stress testing, Kodama and colleagues 65 
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as did normal weight individuals. Therefore, in this major meta-analysis, CRF was more important than weight for predicting major health outcomes. Additionally, CRF plays a major role in predicting prognosis in those with metabolically healthy obesity.
66-68
Impact of CRF on the Obesity Paradox
Several studies have indicated that CRF markedly alters the relationship between fatness and prognosis in both CHD 29 and HF, 69 as well as in Veterans referred for stress testing. 58, 70, 71 In a study of nearly 10,000 patients with CHD followed for almost 14 years, only those in the bottom tertile of ageand gender-related levels of CRF demonstrated an obesity paradox, which was present by BMI, % BF, and even by WC or central obesity in the unfit (Figure 3) . 29 On the other hand, CHD patients with relatively preserved CRF (e.g., not in the bottom tertile) had a favorable prognosis regardless of their level of adiposity, so no obesity paradox was present among the fit CHD patients. Similarly, in a very recent study of over 18,000 Veterans, 71 the obesity paradox was evident when CRF status was not considered. When the cohort was stratified according to their CRF status assessed by treadmill exercise test (low, moderate and high-Fit; Figure 4 ), mortality risk was progressively higher with decreased CRF within each of the four BMI categories and, particularly, within the lowest BMI category (18.5-20.0 kg/m2). However, the paradoxical BMI-mortality risk association was evident only for moderate and low-fit individuals, whereas the mortality risk was no longer elevated for high-fit individuals with low BMI (<24 kg/m 2 ). These findings suggest that increased CRF status negates the elevated mortality risk present in Veterans with low BMI, thus representing the obesity paradox. Furthermore, these findings suggest that the paradoxically higher mortality risk observed in those with relatively low BMI may in part be the result of loss in body weight (and perhaps lean body mass) associated with occult disease. In a cohort of 2,066 systolic HF patients in a cardiopulmonary stress testing database,
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oxygen consumption < 14 mlO 2 •kg -1
•min -1 had a poor prognosis and a strong obesity paradox was present, with the best survival noted in the obese, worst in those with normal BMI (underweight BMI was excluded), and intermediate survival was noted in the overweight BMI ( Figure 5) . 69 On the other hand, those systolic HF patients with relatively preserved CRF (peak oxygen consumption ≥ 14 mlO 2 •kg
) had a good overall prognosis with no obesity paradox. A recent study in systolic HF confirmed these findings. 72 In contrast, however, a study by Uretsky et al 73 of more than 5,000 patients with normal nuclear perfusion stress tests, demonstrated an obesity paradox regardless of CRF.
Nevertheless, those with relatively preserved CRF (≥ 6 estimated METS) have an extremely low mortality of < 1% per year, although the normal BMI had a slightly higher mortality (1.4% per year) compared with 0.9%/year and 0.6%/year in the overweight and obese groups, respectively. It is important to emphasize, however, that none of the studies have adequately assessed the role of CRF on prognosis in moderate and, especially, severe obesity. 69, 74 Additionally, regarding AF, there is also evidence to suggest that PA is associated with small reductions in the risk of incident AF, even in the presence of overweightness. 46, 75, 76 Also, CRF has been found to be a predictor of arrhythmia-free survival with or without rhythm control strategies. 77 In fact, baseline CRF, gain in CRF of ≥ 2 METs, and weight loss were all associated with greater AF-free survival; a gain of ≥ 2 METs in CRF resulted in a two-fold greater chance of AF-free survival.
Potential Benefits of Purposeful Weight Reduction
Despite the obesity paradox, there are still potential beneficial effects of purposeful weight reduction. [3] [4] [5] [6] 78, 79 Whereas weight loss has been questioned, with weight loss being associated with increased mortality in some studies, 80 purposeful weight loss during increased PA and exercise training is
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associated with considerable benefits in patients with CVD, [3] [4] [5] [6] 78, 79 although a recent large study in DM did not demonstrate survival benefits from small amounts of weight loss. 81 In a recent meta-analysis by Park et al 82 of 12 studies and 14 cohorts (n > 35,000), overall weight reduction was associated with a significant 30% increase in major CVD events. However, while observational weight loss in 10 cohorts was associated with a marked 62% increased risk of CVD events, presumed intentional weight loss in 4 cohorts was associated with a significant 33% reduction in risk.
Likewise, another meta-analysis of 15 randomized control trials of 17,186 participants demonstrated that purposeful weight loss in obesity was associated with approximately a 15% reduction in all-cause mortality. 83 Additionally, in AF discussed above, recent evidence suggest that weight loss, with avoidance of weight fluctuation, was associated with a dose-dependent, long-term reduction in AF burden. 46, 84 In fact, reduction of body weight > 10% was found to be associated with a 6-fold greater probability of arrhythmia-free survival when compared to those individuals who lost 3-9% or < 3% of body weight. 80 However, of note, weight fluctuation of ≥ 5% partially offset these benefits with a 2-fold increased risk of AF recurrence. A C C E P T E D M A N U S C R I P T
